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Cell DeathInvertebrate and vertebrate vestigial (vg) and vestigial-like (VGLL) genes are involved in embryonic
patterning and cell fate determination. These genes encode cofactors that interact with members of the
Scalloped/TEAD family of transcription factors and modulate their activity. We have previously shown that, in
mice, Vgll2 is differentially expressed in the developing facial prominences. In this study, we show that the
zebraﬁsh ortholog vgll2a is expressed in the pharyngeal endoderm and ectoderm surrounding the neural crest
derived mesenchyme of the pharyngeal arches. Moreover, both the FGF and retinoic acid (RA) signaling
pathways, which are critical components of the hierarchy controlling craniofacial patterning, regulate this
domain of vgll2a expression. Consistent with these observations, vgll2a is required within the pharyngeal
endoderm for NCC survival and pharyngeal cartilage development. Speciﬁcally, knockdown of Vgll2a in
zebraﬁsh embryos using Morpholino injection results in increased cell death within the pharyngeal arches,
aberrant endodermal pouch morphogenesis, and hypoplastic cranial cartilages. Overall, our data reveal a
novel non-cell autonomous role for Vgll2a in development of the NCC-derived vertebrate craniofacial
skeleton.Artinger).
, Stanford, CA 94305.
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The vertebrate craniofacial skeleton develops as a result of the
speciﬁcation, patterning, morphogenesis, and growth of tissues derived
from all three germ layers in response to a complex network of
reciprocal signaling (Chai and Maxson, 2006; Knight and Schilling,
2006). Ecto-mesenchymal neural crest cells (NCCs) are speciﬁed at the
border between the neural and non-neural ectoderm and migrate
ventro-laterally to populate the pharyngeal arches, a metameric series
of bulges along the lateral surface of the developing head (Eisen and
Weston, 1993; Le Douarin, 1982; Meulemans and Bronner-Fraser,
2004). The arches are separated from one another by pharyngeal
pouches, invaginations of the endoderm lining the pharynx that contact
the surface ectoderm of the embryo (Graham et al., 2005). Recent
studies have demonstrated the importance of the pharyngeal endoderm
and ectoderm in segmenting, patterning and promoting survival of the
NCC-derived mesenchyme that, largely in response to these cues, gives
rise to the pharyngeal skeleton. In the absence of the pharyngeal
endoderm, as in the zebraﬁsh cas/sox32mutant or as a result of physical
ablation in chicken embryos, the pharyngeal cartilages fail to form
(Couly et al., 2002; David et al., 2002). Speciﬁc factors expressed withinthe endoderm, such as TBX1, FGF3, FGF8, and EDN1, have also been
shown to be important for cranial neural crest development (Arnold et
al., 2006; Choudhry et al., 2010; David et al., 2002; Walshe and Mason,
2003). In addition, elements of the pharyngeal skeleton also fail to form
in the absence of facial ectoderm (Hall, 1981) and expression of FGF8,
EDN1, AP2a, SHH, TGF-β andWNT/β-catenin signaling in the ectoderm
(Hu and Helms, 1999; Macatee et al., 2003; Nair et al., 2007; Reid et al.,
2010; Wang et al., 2010; Xu et al., 2008) are important for proper gene
expression and morphogenesis of the underlying NCC mesenchyme.
Our interest in identifying novel players in craniofacial development
led us to perform a microarray screen aimed at identifying novel genes
that are differentially expressed in the mouse face. One gene that was
particularly enriched in the mandibular and maxillary prominences at
embryonic day 10.5 was vestigial-like 2 (Vgll2, also known as VITO1 or
Vgl-2), which encodes amember of the Vg/VGLL-family of transcription
cofactors. Members of this family are expressed in invertebrates and
vertebrates and have been shown to be involved in a variety of
developmental processes. InDrosophila, Vestigial (Vg) interactswith the
transcription factor Scalloped (Sd) to regulate myogenesis and wing
development (Bate and Rushton, 1993; Kim et al., 1996; Paumard-Rigal
et al., 1998; Simmonds et al., 1998;Williams et al., 1991). The vertebrate
Vg and Sd homologs, VGLL1-4 and TEAD1-4 respectively, contain
conserved interaction domains and in vitro studies show that Vgll2 and
Tead-1 (also known as TEF-1) physically interact via these domains
(Chen et al., 2004; Gunther et al., 2004; Maeda et al., 2002). The
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differentiation, modulating binding of Tead-1 to the MCAT recognition
sequences and altering expression of myogenic genes. TEAD factors are
broadly expressed during development and it is thought that more
discrete expression of the interacting cofactors, such as Vgll2, confers
tissue speciﬁcity to TEAD activity (Bonnet et al., 2010; Chen et al., 2004).
Vgll2 is expressed in a conserved pattern during development in all
vertebrates examined. In the mouse, Vgll2 is expressed beginning at
embryonic day 8.0 (E8.0) in the pharyngeal arches and, by E9.5, in the
myotomes of the somites and other sites of myogenesis (Maeda et al.,
2002; Mielcarek et al., 2002). Expression of VGLL2 is similar in chick
and Xenopus, with the notable exception that it is also expressed in
ventral domains within the brain in these organisms (Bonnet et al.,
2010; Faucheux et al., 2010). The zebraﬁsh genome contains two
VGLL2 orthologs, vgll2a and vgll2b (also known as vgl-2a and vgl-2b)
(Mann et al., 2007). vgll2b is expressed in the notochord and
developing skeletal muscle but expression within the pharyngeal
arches has not been described (Mann et al., 2007).
Here we report that vgll2a is expressed in the pharyngeal
endoderm and ectoderm in zebraﬁsh. Injecting zebraﬁsh embryos
with antisense Morpholino oligonucleotides (MO) to reduce Vgll2a
induces neural crest cell death within the pharyngeal arches at 24 hpf,
resulting in hypoplasia of the pharyngeal skeleton. We also demon-
strate that expression of vgll2a within the pharyngeal epithelia is
regulated by FGFs and RA and may represent an intersection of these
signaling pathways in regulating NCC survival and craniofacial
development.
Materials and methods
Animal maintenance
Zebraﬁsh were maintained according to Westerﬁeld (2007) and
staged according to Kimmel et al. (1995). AB and TL wild-type lines
were used. The p53 mutant ﬁsh line, tp53M214K, has been previously
described (Berghmans et al., 2005). p53−/−ﬁsh were obtained by
incrossing p53+/−heterozygotes and genotyped by PCR with the
forward primers 5′-AGCTGCATGGGGGGGAT-3′ for the wild-type
allele or 5′-AGCTGCATGGGGGGGAA-3′ for the mutant allele and the
reverse primer 5′-GATAGCCTAGTGCGAGCACACTCTT-3′. Genotyped
p53−/−ﬁsh were then incrossed to obtain p53−/−embryos for
experiments. The sox10:egfp (Tg(−4.9sox10:egfp)ba2) line has also
been previously described (Carney et al., 2006).
C57BL/6J mice (Jackson Labs) were maintained as previously
described (Feng et al., 2009).
Knockdown of vgll2a
Vgll2a knockdown was accomplished by injecting embryos at the
1 to 4 cell-stage with a mixture of 2.5% ﬂuorescein dextran
(10,000 MW, lysine ﬁxable, Invitrogen) and 5 ng of antisense
Morpholino oligonucleotides (MOs) with the sequence TTG GGT
TGC ATC AGA GGC TTA C (vgll2a ATG MO), targeting the translation
start site (Gene Tools, LLC). At 24 hpf, embryos were screened using a
ﬂuorescence stereomicroscope and only embryos with consistent
ﬂuorescein incorporation were used in subsequent analysis. To verify
that the phenotypes observed in this morphant were the result of
reduced Vgll2a rather than an off-target, embryos were also injected
with a second Morpholino, TTG GGT TGC ATC AGA GGC TTA C (vgll2a
e2i2 MO), targeting the second exon–intron splice junction of the
mRNA. Targeting by this Morpholino is predicted to result in skipping
of the second (TEAD interacting domain containing) exon during
splicing of the vgll2a mRNA (Morcos, 2007). Translation of such a
message should result in a frameshift mutation within exon three and
a premature stop codon 102 nucleotides downstream of the initiating
ATG. mRNA from 10 pooled, 24 hpf embryos injected with 10 ngvgll2a 2e2i MO or 10 uninjected embryos was isolated using the
RNAeasy Micro Kit (Qiagen) and reverse transcribed into cDNA
using the Superscript III First-Strand Synthesis System for RT-PCR
(Invitrogen). RT-PCR of the entire vgll2a CDSwas performed using this
cDNA and forward primer 5′-ATG AGC TGC TTGGAT GTC ATG TAT C-3′
and reverse primer 5′-TTA AAA CCA GTA CAA GTC CTT GCT C-3′, while
β-actin was ampliﬁed with forward primer 5′-CGA GCT GTC TTC CCA
TCC A-3′, and reverse primer 5′-TCA CCA ACG TAG CTG TCT TTC TG-3′.
Interestingly, the expected incorrectly spliced vgll2a product was not
observed, though the early stop codon associated with this message
would likely result in its degradation by nonsense-mediated decay.
Integrated densities for each band were measured using Adobe
Photoshop CS3 (Adobe Systems Inc.) and the densities of vgll2a bands
were normalized to the β-actin bands. This revealed that embryos
injected with 10 ng vgll2a 2e2i MO exhibited a 44% decrease in vgll2a
message (Supplemental Fig. 1B). Embryos injected with 10 ng vgll2a
2e2i MO and stained for cartilage at 5 dpf exhibited similar
craniofacial phenotypes as those embryos injected with the vgll2a
ATG MO (compare Supplemental Figs. 1A to 2D), suggesting these
MOs are likely both targeting vgll2a. Because the vgll2a ATG MO
resulted in a stronger and more consistent phenotype at a lower dose,
we used this morpholino for all subsequent knockdown experiments.
To further verify speciﬁcity of the vgll2a ATGMO, an experiment to
rescue the cartilage phenotype observed in embryos injectedwith this
MO by co-injection of vgll2a mRNA was performed. A template for
vgll2a mRNA was constructed by amplifying a ~875 bp fragment of
the vgll2a cDNA from IMAGE cDNA clone 7452668 (Open Biosystems)
using forward primer 5′-GAT CCT CGA GCC ACC ATG TCA TGT CTT GAC
GTC ATG TAT CAA GTT TAT GGT CCA C-3′, which has an altered
sequence so this mRNA will not be targeted by the vgll2a ATG MO
but still encodes the same amino acid sequence, and reverse primer
5′-GTT CTC TAG ATT ATT AAA ACC AGT ACA AGT CCT TGC TC-3′. The
resulting product was cloned into pCR®II-TOPO® (Invitrogen). This
clone was digested using Acc65I and SP6 polymerase was used to
synthesize capped, polyadenylated mRNA using the mMESSAGE
mMACHINE kit (Ambion). Injection of 100 pg of the resulting
vgll2aΔMO mRNA caused no obvious developmental phenotype, but
greater amounts resulted in severe edema, small or absent eyes, mild
hypoplasia of the pharyngeal skeleton, and curved bodies (data not
shown), most likely due to unregulated activity of Vgll2a. Embryos
were injected as described above with either 6 ng ATG MO alone or
6 ng ATGMO alongwith 100 pg vgll2aΔMOmRNA injected at the one-
cell stage. At 5 dpf we stained the cartilage of these larvae and counted
the number of alcian-blue-positive pharyngeal cartilage elements that
were observed (Supplemental Fig. 2). While injection of 6 ng vgll2a
ATG MO alone resulted in a loss of almost all pharyngeal cartilages
(Supplemental Fig. 2B), co-injection with 100 pg of vgll2aΔMOmRNA
resulted in the development of a greater number of pharyngeal
cartilage elements (Supplemental Figs. 2C,D). The partial rescue of the
vgll2a morphant phenotype by con-injection with vgll2aΔMO mRNA
suggests that the vgll2a ATG MO speciﬁcally targets vgll2a.
To suppress p53 mediated, MO-induced cell death (Robu et al.,
2007), all MO injections were carried out in p53−/−embryos with the
exception of NCC migration analysis, in which sox10:egfp embryos
were co-injected with 5 ng of the vgll2a ATG MO and 2 ng of p53 MO
with the sequence 5′-GCG CCA TTG CTT TGC AAG AAT TG-3′ (Gene
Tools, LLC; Robu et al. 2007), and transplant experiments, which were
conducted using wild-type embryos.
Skeletal staining
Cartilage was stained following Walker and Kimmel, 2007, with
some modiﬁcations. 5 dpf larvae were ﬁxed in 2% PFA for 1 h at room
temperature, washed in 100 mMTris pH 7.5/10 mMMgCl2, and stained
overnight in 0.04% alcian blue (Anatech Ltd) in 80% EtOH/100 mM
Tris pH 7.5/10 mM MgCl2. Larvae were then rehydrated in 80%
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EtOH/100 mM Tris pH 7.5, washed in 3% H2O2/0.5% KOH to remove
pigment, cleared in 25% glycerol/0.1% KOH, and stored in 50%
glycerol/0.1% KOH.
Whole-mount in situ hybridization
Zebraﬁshwhole-mount in situhybridization (ISH)wasadapted from
Thisse andThisse (1998) and Brent et al. (2003). BMPurple (Roche)was
used as a substrate for the alkaline phosphatase reaction. A template for
a vgll2a antisense riboprobe was constructed by amplifying an 871 bp
fragment of the vgll2a cDNA from IMAGE cDNA clone 7452668 (Open
Biosystems) using forward primer 5′-GCT GCT TGG ATG TCA TGT ATC
AAG-3′ and reverse primer 5′-GTC CTT GCT CTT ATC TTG GCT CTA-3′.
The resulting product was cloned into pCR®II-TOPO® (Invitrogen). This
clone was digested using HindIII and T7 polymerase was used to
synthesize an antisense probe to detect vgll2a expression. A template for
vgll2b antisense riboprobe was constructed by cloning a 361 bp PvuII
fragment isolated from IMAGE cDNA clone 7284235 (Open Biosystems)
into pCR®-Blunt II-TOPO® (Invitrogen). This plasmidwas digestedwith
SpeI, and an antisense probe was synthesized using T7 polymerase.
Other riboprobes used were dlx2a and dlx5a (Akimenko et al., 1994),
edn1 (Miller et al., 2000), fgf3 (Maves et al., 2002), fgf10a (a gift fromDr.
David Stock), hand2 (Yelon et al., 2000), nkx2.3 (Lee et al., 1996), nkx3.2
(Miller et al., 2003), shh (Krauss et al., 1993), sox9a (Chiang et al., 2001),
and tbx1 (Piotrowski et al., 2003).
For sectional analysis of vgll2a expression, after ISH, embryos were
dehydrated through an ethanol series, embedded in JB-4 glycol
methacrylate polymer (Polysciences Inc.) and sectioned at 4 μm using
glass knives.
ISH of Vgll2 in the mouse was performed as previously described
(Feng et al., 2009).
Immunoﬂuorescence
Embryos were ﬁxed in 4% PFA for 1 h at room temperature. For
permeabilization, 24 and 48 hpf embryos were washed in distilled H2O
for 2×5 min, while 72 hpf embryos were washed for 5 min in distilled
H2O, 5 min in 100% acetone at −20 °C, and another 5 min in distilled
H2O. Subsequent steps were carried out as described (Ungos et al.,
2003). Primary antibodies used were zn-8 (anti-Alcama) (1:250;
Developmental Studies Hybridoma Bank), anti-phospho-histone H3
(1:500; Millipore), and anti-active caspase-3 (1:250; BD Pharmingen),
followed by Alexa Fluor® 488 or Alexa Fluor® 594 conjugated
secondary antibodies (1:750; Molecular Probes).
Transplantations
Wild-type embryoswere injected at the one-cell stagewith 1 ng cas/
sox32 mRNA (previously described, Dickmeis et al., 2001) synthesized
with the mMESSAGE mMACHINE kit (Ambion) and 2.5% rhodamine
dextran (tetramethylrhodamine dextran, 10,000 MW, lysine ﬁxable,
Invitrogen). At mid blastula stages, embryos were dechorionated and
approximately 50 cells from the margin of these endodermally fated
donor embryos were transplanted to the margin of wild-type embryos
injected with 5 ng vgll2a ATG MO. At 30 hpf, embryos were screened
using a ﬂuorescence stereomicroscope and only those with pharyngeal
endoderm-speciﬁc contribution of donor cells were used in subsequent
analysis. At 5 dpf, embryos were ﬁxed and cartilage was stained as
described above.
Pharmacological treatments
At 23 hpf, manually dechorionated embryos were transferred into
embryo media containing 20 μM SU5402 (3-[3-(2-carboxyethyl)-4-
methylpyrrol-2-methylidenyl]-2-indolinone; CalBiochem;Mohammadiet al., 1997), 100 μM DEAB (4-(Diethylamino)benzaldehyde; Sigma-
Aldrich), 100 nMall-trans retinoic acid (Sigma-Aldrich) or 0.2%DMSOas
a carrier control and incubated at 28.5 °C in the dark. After one hour,
embryos were ﬁxed in 4% PFA and processed by ISH.
Microarray
Mandibular, maxillary, and frontonasal prominences were collect-
ed at ﬁve time points between E10.5 and E12.5 from C57BL/6J
(Jackson Labs) mouse embryos and analyzed by microarray using
seven replicates for each sample as previously described (Feng et al.,
2009).
Imaging and analysis
Processed embryos were mounted in glycerol and, for ISH and
skeletal staining, imaged on a Zeiss Stemi SVII dissecting microscope
or, for greater magniﬁcation, an Olympus BX51WI compound
microscope using a SPOT RT Slider camera and SPOT Software
(Diagnostic Instruments, Inc.). ISH domains were measured using
Adobe Photoshop CS3 (Adobe Systems Inc.).
For immunoﬂuorescence, confocal images were captured on a
Zeiss LSM 510 NLO using AxioVision software (Carl Zeiss). To quantify
cell death and proliferation, Z stack projections of 3 μm confocal slices
were analyzed using Imaris software (Bitplane Inc.).
Results
Previously, a microarray screen was performed comparing gene
expression in the mouse mandibular, maxillary, and frontonasal
prominences at ﬁve time points from embryonic day 10.5 (E10.5) to
E12.5, during which these prominences undergo substantial growth,
fusion, and morphogenesis (Feng et al., 2009). It was reasoned that
genes differentially expressed in these samples might represent
molecules with roles in these developmental processes. We were
particularly interested in identifying those genes for which a role in
orofacial development had not been described. One such gene
identiﬁed in this screen was vestigial-like 2 (Vgll2). In our microarray
studies, we found that Vgll2 expression was enriched in samples from
the mandibular and maxillary prominences at E10.5 but not at later
time points and not in samples from the frontonasal prominence
(Supplemental Fig. 3A). To conﬁrm this ﬁnding, we performed RNA in
situ hybridization (ISH) and found that Vgll2 is expressed in the
epithelia of the mandible and maxilla in the commissure of the
developing mouth at E10.5 (Supplemental Fig. 3B). We also found
Vgll2 to be expressed in the pharyngeal pouches and somites, as has
been previously described (Maeda et al., 2002; Mielcarek et al., 2002).
In order to determine the function of Vgll2 in craniofacial develop-
ment, we utilized the zebraﬁshmodel and examined the expression of
the two Vgll2 homologs, vgll2a and vgll2b, to assess if transcripts
derived from these genes were present in the facial complex.
vgll2a expression in the developing zebraﬁsh
ISH analysis was used to examine expression of vgll2a in zebraﬁsh
at stages from 1-cell to 77 h post fertilization (hpf). vgll2a is ﬁrst
expressed at the 2-somite stage (10.75 hpf) in the developing somites
(Fig. 1A), where it continues to be expressed throughout somitogen-
esis (Figs. 1A–D). vgll2a is also faintly expressed in the notochord at
these stages (data not shown). At 17 somites (17.5 hpf), vgll2a
continues to be expressed in the somites (arrow, Fig. 1B) and begins to
be expressed in discrete cell populations within the pharyngeal
endoderm as they begin to evaginate to form the ﬁrst endodermal
pouch that separates arches one and two (arrow Figs. 1C). At 22 hpf
(Figs. 1D, E), expression of vgll2a is apparent in both the endoderm
(black arrow) and ectoderm (white arrow) that surround the
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posterior wave. At 30 hpf, expression of vgll2a was apparent in the
region of the developing trigeminal ganglion (arrow; Fig. 1F).
Sectional analysis of embryos at 30 hpf conﬁrmed that vgll2a is also
prominently expressed in the pharyngeal endoderm and, to a lesser
extent, the overlying ectoderm (Figs. 1H–I). Expression of vgll2a was
also apparent in the ventral forebrain (arrowheads Figs. 1D and G)and this expression domain expands at later stages. Endodermal
expression persists at later stages as the pouches continue their
morphogenesis and fuse with the ectoderm to form gill slits between
the arches (black arrow, Figs. 1J–L). vgll2a begins to be expressed in
the ﬁn buds by 40 hpf (Fig. 1J), in the developing cranial musculature
by 48 hpf (Fig. 1K) and at 64 hpf, vgll2a is re-expressed in the now
mature somitic muscle (Fig. 1L). Expressionwithin the notochord was
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mouse, vgll2a is also expressed in lateral edges of the stomodeum, the
presumptive mouth, (white arrow, Fig. 1J, Supplemental Fig. 5A) and
the commissure of the mouth after it opens (white arrow, Figs. 1K–L,
Supplemental Fig. 5B).
Expression of the other zebraﬁsh VGLL2 paralog, vgll2b, has been
previously examined at early stages (N24 hpf) and is observed in the
notochord and somites in a pattern similar to vgll2a. We used ISH to
examine expression of vgll2b at 24, 48, and 72 hpf and found that,
unlike vgll2a, vgll2b is not expressed in the pharyngeal epithelia
(Supplemental Fig. 4). Other domains of expression appear to be
relatively conserved between these paralogs at the stages analyzed.
Our analysis shows that vgll2a and vgll2b are expressed in
zebraﬁsh in patterns similar to previously reported for VGLL2 in
other vertebrates (Bonnet et al., 2010; Faucheux et al., 2010; Maeda et
al., 2002; Mielcarek et al., 2002). These data also provide support for a
role for vgll2a, but not vgll2b, in the development of the pharyngeal
skeleton.
vgll2a is required for cartilage development and endodermal pouch
morphogenesis
To determine if vgll2a is required for development of the
pharyngeal skeleton, we reduced Vgll2a function in zebraﬁsh embryos
using antisense Morpholino oligonucleotides (MO) targeting the
translation start site of the message (vgll2a ATG MO) injected at the
one to four cell stage. Following injection of 5 ng of vgll2a ATG MO,
embryos exhibit a reduction in size of the overall jaw structure as
compared with controls at 5 dpf (Figs. 2A, B; n=66/72). Alcian blue
staining revealed hypoplasia or loss of cartilages of the viscerocra-
nium in embryos injected with 5 ng vgll2a ATG MO relative to
uninjected controls (Figs. 2C,D). Cartilages derived from the ﬁrst arch,
Meckel's (m) and palatoquadrate (pq) cartilages, are severely
hypoplastic in vgll2a morphants relative to uninjected controls
(Figs. 2E,F). This is also observed in second arch derivatives, including
ceratohyal (ch) and hyosymplectic (hs) cartilages. Most of the skeletal
derivatives of the posterior arches, the ceratobranchial (cb) cartilages,
are absent (Figs. 2E, F). The ethmoid plate of the neurocranium was
also truncated in Morpholino injected animals relative to controls
(Figs. 2G, H). These data suggest that Vgll2a is required for craniofacial
skeletal development in the zebraﬁsh. While a more severe
hypoplasia of the pharyngeal skeleton can be observed with injection
of higher amounts of vgll2a ATG MO (see Supplemental Fig. 2), in the
interest of avoiding non-speciﬁc knockdown of off-target genes, we
decided to perform experiments using the 5 ng dose.
Theprominent expressionof vgll2awithin thepharyngeal endoderm
led us to examine this tissue in vgll2amorphants. At 38 hpf, when all of
the pouches have formed, we used the zn-8 antibody, which recognizes
Alcama and is a marker of the pharyngeal endoderm (Choudhry et al.,
2010; Fashena and Westerﬁeld, 1999; Trevarrow et al., 1990), to
visualize the pharyngeal pouches in morphant embryos and uninjected
controls. The pharyngeal pouches of morphant embryos appeared
shorter andwider than uninjected controls, suggesting that Vgll2a playsFig. 1. vgll2a expression in the developing zebraﬁsh. In situ hybridization (ISH) using a vgll2
(K) and 64 hpf (L) stages showing lateral (A, B, D, F, J, K, L), dorsal (C, E) or ventral (inset, L) vi
F. vgll2a is ﬁrst detected in the developing somites (black arrows, A and B) of zebraﬁsh at
population of endodermal cells (black arrow, C) as they evaginate to form the ﬁrst pharyngea
the lateral pharyngeal endoderm (black arrows, D, E) as the pouches continue to form, a
arrowhead, D). At 30 hpf, expression of vgll2a is also apparent in the region of the developing
plastic sections of 30 hpf embryos (G, H, I) reveal that vgll2a expression, in addition to be
arrowhead, G) and prominently in the pharyngeal pouch endoderm (H, and black arrow i
pharyngeal ectoderm (white arrow, I). From 30 to 48 hpf (F–K), vgll2a continues to be ex
forebrain expression expands. At 40 hpf and later stages, vgll2a is expressed in the stomodeu
in sites of myogenesis other than the somites, including the ﬁn bud (fb) and cephalic m
expression is more apparent by 64 hpf (L), at which time vgll2a becomes reactivated in the s
operculi; hh, hyohyoideus; ih, interhyoideus; ima, intermandibularis anterior; imp, interma
so, superior oblique; sr, superior rectus.a role in morphogenesis of the endodermal pouches (Figs. 3A, B).
The presence of Alcama in the pouch endoderm as detected by the zn-
8 antibody suggests that Vgll2a is not required for the speciﬁcation of
this tissue. To conﬁrmproper speciﬁcation of the pharyngeal endoderm,
we examined the expression of genes including: fgf3, which is expressed
in pharyngeal pouches at 24 hpf; nkx2.3, which is expressed in the
pharyngeal endoderm and ectoderm surrounding the arches at 24 hpf;
end1,which is expressed in the endoderm, ectoderm, andmesoderm of
the arches at 24 hpf; tbx1, which is expressed in the pharyngeal
endoderm and mesoderm at 30 hpf; and shh, which is expressed in
pouch two and the oral ectoderm at 48 hpf (Supplemental Fig. 6).
Expression of these genes within the pharyngeal endoderm is
essentially unchanged in vgll2a morphants relative to uninjected
controls, providing further support for the proper speciﬁcation of the
pharyngeal epithelia when vgll2a is reduced. Together, these results
suggest that Vgll2a is required for proper morphogenesis of the
pharyngeal endoderm, but not for its speciﬁcation.
Neural crest cell death within the arches is increased in vgll2a
morphants
We next utilized ISH to determine how earlier defects in cranial
NCCs might contribute to the hypoplastic cartilage defects in the
Vgll2a morphants. We utilized probes speciﬁc for the homeodomain-
containing transcription factors dlx2a at 24 hpf, when it is expressed
in all NCCs of the pharyngeal arches (Figs. 4A–B), and barx1, a marker
of condensations of cranial NCCs as they undergo chondrogenesis, at
48 hpf (Figs. 4D–E). While these genes were expressed in similar
domains in uninjected and vgll2a MO injected embryos, the areas of
the expression domains appeared reduced. To quantify this, we
measured the area of each expression domain and compared the
measurements from vgll2a morphants to those from uninjected
embryos. All of the dlx2a domains measured are signiﬁcantly smaller
in vgll2amorphants (Fig. 4C). Similarly, all of the barx1 domains, with
the exception of the ventral domain of arch 2, are also signiﬁcantly
smaller in morphants relative to uninjected controls (Fig. 4F).
Expression of barx1 is notably absent in all but the most posterior
ceratobranchial condensations of arches 3–5 in vgll2a morphants
(bracket, Fig. 4E).
To conﬁrm proper speciﬁcation of cranial NCCs we examined
expression of genes normally expressed in arch NCCs, including
fgf10a, dlx5a, hand2, nkx3.2 (also known as bapx1), and sox9a at stages
throughout development (Supplemental Fig. 7). Like dlx2a and barx1,
these genes are expressed in vgll2a morphants, but their domains of
expression appear smaller in size relative to uninjected control
embryos. Like barx1, however, sox9a appeared to be absent in the
posterior arches. Together, these data suggest that while NCCs are
generally speciﬁed and patterned correctly in vgll2a morphants, they
appear reduced in number.
In order to determine if this reduction in NCCs within the arches
might be attributed to a gross defect in themigration of these cells, we
examined their migration in sox10:egfp transgenic embryos, which
express EGFP speciﬁcally in NCCs. At 16, 17, and 18 hpf, we observeda probe at 2 somites (A), 17 somites (B, C), 22 hpf (D, E), 30 hpf (F–I), 40 hpf (J), 48 hpf
ews. 4 μmplastic sections (G, H, I) of 30 hpf embryos sectioned in planes shown in panel
the 2-somite stage (A). By 17 somites (B,C), vgll2a is also expressed at low levels in a
l pouch. At 22 hpf, lateral (D) and dorsal (E) views reveal that vgll2a is also expressed in
s well as in the pharyngeal ectoderm (white arrow, E) and ventral forebrain (black
trigeminal ganglion (black arrow, F) Dashed lines indicate plane of section in G–I. 4 μm
ing expressed within a discrete population of cells within the ventral forebrain (black
n higher magniﬁcation view of boxed region in, I), is also expressed in the overlying
pressed in the endodermal pouches (black arrow, J,K), somite expression fades, and
m, the presumptive mouth (white arrow, J, K, L). By 48 hpf (K), it begins to be expressed
usculature and is also apparent in the notochord (black arrowhead). Cranial muscle
omitic muscle. Anterior is to the left in all panels. am, adductor mandibulae; do, dilator
ndibularis posterior; io, inferior oblique; lap, levator arcus palatini; sh, sternohyoideus;
Fig. 2. Pharyngeal cartilage development is affected in vgll2amorphants. Uninjected (A,C,E,G) and vgll2amorphant (B,D,F,H) embryos at 5 dpf (A,B) and alcian blue staining of these
embryos (C–H) in whole mount (C,D), and after dissection to isolate the viscerocranium (E,F) and neurocranium (G,H). A typical embryo injected with 5 ng vgll2a ATG morpholino
(B) exhibits a reduction in jaw structure relative to an uninjected control (A). Staining of the cranial cartilages with alcian blue inwhole mount (C–D) and in dissected embryos (E–H)
reveals the absence of the ceratobranchials 1–5 and hypoplastic Meckel's, palatoquadrate, ceratohyal and hyosymplectic cartilages in vgll2a morphants (F) relative to uninjected
controls (E). Additionally, the anterior part of the neurocranium, the ethmoid plate, is truncated in vgll2amorphants (H) relative to controls (G). Anterior is to the left in all panels.
e, ethmoid plate; cb, ceratobranchial; ch, ceratohyal; hs, hyosymplectic; m, Meckel's cartilage; pq, palatoquadrate.
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around the eye and into the frontonasal process of both uninjected
and vgll2a morphant embryos (Supplemental Fig. 8). There are no
obvious differences in migration of cranial NCCs, suggesting that the
decrease in the number of NCCs populating the arches of vgll2a
morphants is not a result of earlier defects in migration. Together,
these data suggest that, while NCCs are speciﬁed, migrate, and are
patterned correctly in vgll2a morphants, they may be reduced in
number.
We next determined if this reduction in cranial NCCs might
be attributed to changes in proliferation or cell death. We used the
zn-8 antibody to visualize the pharyngeal pouches and anti-
phospho-histone H3 or anti-active caspase 3 to identify proliferating
or apoptotic cells, respectively, at 24, 48, and 72 hpf. Within
projected Z-stacks collected using confocal microscopy we modeled
arch volumes in three dimensions based on zn-8 staining and found
that the estimated arch volumes of vgll2a morphant embryos are
smaller than those of uninjected controls (Supplemental Fig. 9),which correlates with the observed reductions in NCC marker
domains (Fig. 4). Individual cells undergoing proliferation or
apoptosis within the modeled arch volumes were counted and
normalized for arch volume. Within these arch volumes, proliferation
is unchanged in vgll2a morphants relative to uninjected controls at all
three time points examined (Supplemental Fig. 10). In contrast, cell
death within the arches is increased seven-fold in vgll2amorphants at
24 hpf, but unchanged at 48 and 72 hpf (Fig. 5). In order to conﬁrm that
the dying cells we observedwithin the arches of vgll2amorphants were
indeed NCCs, we examined cell death using the anti-active caspase 3
antibody in sox10:egfp embryos that express egfp within the NCCs, and
found that while there are no anti-caspase 3-positive cells within the
arch NCCs of uninjected embryos at 24 hpf, dying NCCs can be seen
within the arches of vgll2a MO injected embryos (Supplemental
Fig. 11). Together these data suggest that Vgll2a is required for survival
of cranial NCCs within the arches at around 24 hpf and that the
increased NCC cell death results in fewer NCCs populating the
pharyngeal arches of vgll2a morphants.
Fig. 3. Endodermal pouch morphogenesis is affected in vgll2a morphants. Single
confocal, Z-plane images of an uninjected (A) and vgll2amorphant embryo (B), stained
with the zn-8 antibody, marking the endodermal pouches in lateral views. Uninjected
embryos (A) exhibit elongated endodermal pouches, numbered 1–5, formed by tight
folds of epithelium at 38 hpf. In contrast, the endodermal pouches of embryos injected
with 5 ng vgll2a ATG MO (B) are shorter and wider, and the epithelial cells appear less
organized relative to uninjected controls. Anterior is to the left in both panels.
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Because vgll2a is required for survival of neural crest cells within
the arch, but is expressed most prominently in the pharyngeal
endoderm, we hypothesized that Vgll2a is required primarily within
the pharyngeal endoderm for maintenance of NCCs and subsequent
development of the pharyngeal cartilages.
To test this hypothesis, we transplanted vgll2a expressing cells into
vgll2a morphant embryos and evaluated the ability of these cells to
rescue development of the pharyngeal skeleton. At the blastoderm
stage, cells at the margin of the embryo represent the presumptive
mesendoderm (Kimmel et al., 1990). When transplanted to the margin
of another embryo, however, these cells rarely contribute to the
endoderm (Alexander et al., 1999; David and Rosa, 2001). In order for
transplanted cells to contribute to the endoderm of mosaic embryos,
donor embryos were fated to the endoderm lineage by injection with
mRNA encoding cas/sox32, an endoderm speciﬁcation protein (Chung
and Stainier, 2008) at the one-cell stage (Fig. 6A). At the blastoderm
stage, cells were transferred from themargin of these donor embryos to
the margin of morphant embryos. Co-injection with the lineage tracer
rhodamine dextran allowed us to identify transplanted cells at 30 hpf.
Donor cells often contributed unilaterally to the pharyngeal endoderm of
otherwise vgll2a morphant embryos (Figs. 6B–C). By 5 dpf, these
endodermally fated, wild type cells were able to partially or completely
rescue development of the pharyngeal cartilages in 26% of these mosaic
embryos (Figs. 6D–G). In caseswhere these cartilageswerenot rescuedby
WT endodermal transplant, the number of transplanted cells contributing
to the pharyngeal endodermmay not have been great enough to provide
the number of vgll2a-expressing cells required for development of the
adjacent cartilages. While these results suggest that the pharyngeal
endoderm is a sufﬁcient source of vgll2a for cartilage development to the
extent we describe here, it is possible that expression of vgll2awithin the
overlying ectoderm normally contributes to craniofacial development as
well. This result suggests that vgll2a is required primarily within the
pharyngeal endoderm for development of the facial cartilages.
FGF and RA regulate vgll2a expression within the pharyngeal epithelia
FGF and RA signaling pathways regulate endodermal pouch
morphogenesis (Crump et al., 2004; Kopinke et al., 2006; Linville etal., 2009). FGFs are also required for survival of neural crest cells
within the arches (Abu-Issa et al., 2002; Nissen et al., 2003; Trokovic
et al., 2003; Yang et al., 2010) and both increased or reduced RA can
result in cranial NCC apoptosis, suggesting a particular level of RA
must be present to promote NCC survival (Begemann et al., 2001;
Dickman et al., 1997; Sulik et al., 1988). Our ﬁnding that vgll2a is also
important for these processes led us to hypothesize that vgll2amight
be regulated by FGFs and RA and act as an effector of these signaling
pathways.
To test our hypothesis that vgll2a expression is regulated by FGF
signaling, embryos were treated with SU5402, an inhibitor of the
tyrosine kinase activity of FGF receptors (Mohammadi et al., 1997;
Roehl and Nüsslein-Volhard, 2001), from 23 to 24 hpf. Treated
embryos were then immediately ﬁxed and analyzed by ISH to
evaluate vgll2a expression. When compared to DMSO controls
(Fig. 7A), embryos treated with 20 μM SU5402 exhibit reduced
expression of vgll2a within the pharyngeal epithelia (Fig. 7B) while
expression in other domains remains unaffected (data not shown).
These data suggest that expression of vgll2a within the pharyngeal
pouches is positively regulated by FGF signaling.
We also examined if vgll2a is regulated by RA by treating embryos
from 23 to 24 hpf with 100 μM DEAB, an inhibitor of retinaldehyde
dehydrogenase that reduces endogenous RA synthesis (Kopinke et al.,
2006; Perz-Edwards et al., 2001) or 100 nM all-trans RA, and then
assaying for vgll2a expression using ISH. Treatment with DEAB
increases expression of vgll2a (Fig. 7C) while treatment with RA
results in decreased expression of vgll2a within the pharyngeal
epithelia (Fig. 7D). As with SU5402, neither treatment affects vgll2a
expression in other domains (data not shown). Together these results
demonstrate that RA negatively regulates vgll2a expression within
the endodermal and ectodermal pharyngeal epithelia.
Discussion
In this study, we have demonstrated a role for vgll2a in craniofacial
development that is novel for VGLL family members. We have shown
that vgll2a is expressed and required in the pharyngeal epithelia and
that targeted knockdown of vgll2a leads to increased cell death within
the arches and, subsequently, a reduction in the pharyngeal skeleton.
Finally, we have reported that FGFs and RA, two signaling pathways
that have been identiﬁed as important regulators of craniofacial
development, also regulate expression of vgll2a in an opposingmanner.
Evolutionary conservation of vgll2a and vgll2b expression
We have shown that in the developing zebraﬁsh, vgll2a is
expressed in the endodermal and ectodermal epithelia of the
pharyngeal arches, as well as in the notochord, brain and sites of
myogenesis. Its paralog, vgll2b, is expressed in a similar pattern but,
unlike vgll2a, is not expressed in the pharyngeal arches. VGLL2 is
expressed in the arches of all other vertebrates examined (Bonnet et
al., 2010; Faucheux et al., 2010; Maeda et al., 2002; Mann et al., 2007;
Mielcarek et al., 2002), suggesting that vgll2a and vgll2b represent a
case of genetic duplication and divergence. Some time after
duplication during teleost evolution, vgll2b may have lost a cis-
regulatory element driving expression with the pharyngeal arches.
The similarities and differences in expression of vgll2a and vgll2b also
imply that these paralogs may be functionally redundant in domains
where both paralogs are expressed, such as the developing skeletal
muscle, notochord, and brain, but that vgll2a acts independently from
vgll2b in the development of the pharyngeal arches.
In the mouse, expression of Vgll2 has been observed in the
pharyngeal epithelia (Maeda et al., 2002; Mielcarek et al., 2002), but a
functional, in vivo analysis has not been completed to date, making
this study the ﬁrst to do so in vertebrates. Although little has been
described regarding the expression of human VGLL2 gene, it is located
Fig. 4. vgll2a knockdowncauses a reduction in the sizeofNCCdomains. Later views of representative uninjected (A,D) and vgll2amorphant (B,E) embryos processedby ISHwith probes for
dlx2a at 24 hpf (A,B) and barx1 at 48 hpf (D,E). Dotted lines outlined in panels A,B,D and E represent the domain areas quantiﬁed (C,F). The domains of NCCmarker dlx2a (A,B) in the ﬁrst
three arches (numbered 1–3) are smaller in vgll2a morphants (B) relative to uninjected controls (A) at 24 hpf. barx1 is expressed in cranial NCC condensations at 48 hpf (D,E) and
expression domains including the neurocranium and arch 1 (1/n), dorsal and ventral domains within arch 2 (2d and 2v) and a domain representing arches 6 and 7 (6/7) are similarly
reduced in vgll2amorphants (E) relative to controls (D). barx1 expression in the anterior ceratobranchials (bracket, D,E) was not detected in vgll2amorphant embryos (E). Graphs of the
average area in these embryos reﬂect these differences (C, F). Error bars represent standard error of themean. All domainsmeasuredwere signiﬁcantly smaller in vgll2amorphants except
2v (Student's T Test,*: pb0.05, **: pb0.01, ***: pb0.001). Scare bars=100 μm. Numbers at the base of each bar represent the number of embryos counted for each condition.
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linked to an autosomal recessive form of craniometaphyseal dysplasia,
a disorder that causes, among other defects, hyperostosis of the bones
of the face (Iughetti et al., 2000). Thus, it would be interesting to
determine if VGLL2 plays a similar role in mammals and might
contribute to the etiology of this disease.
vgll2a in cell death
Reduction of Vgll2a function results in hypoplasia of the facial
cartilages. The remaining cartilaginous elements in vgll2amorphants,
however, are patterned appropriately and markers for craniofacial
development are generally expressed in the appropriate locations.
While it is possible that NCCs are affected by other defects that we
were unable to detect in our analysis, our data suggest that vgll2a does
not play a role in migration, speciﬁcation, or patterning of the cranial
NCCs pharyngeal skeleton, but may be important for regulating cell
number. In support of this idea, both the size of the craniofacial
cartilages and the NCC marker domains were reduced in vgll2a
morphants suggesting a change in NCC number. Indeed, we see an
increase in apoptosis within the pharyngeal arches, but no change in
cell proliferation, in vgll2a morphants. Together, these data suggest
that vgll2a is required for maintenance of cranial NCC cells. While notall arch NCCs undergo apoptosis in embryos injected with 5 ng vgll2a
ATG MO as was used in our analysis of cell death, it is likely that this
dose does not result in complete knockdown of the gene. Indeed,
injection with higher doses of vgll2a ATG MO resulted in stronger
pharyngeal cartilage phenotypes (Supplemental Fig. 2). As such, the
vgll2a morphants described here probably do not reﬂect the full
extent of cell death that might occur with complete knockdown of the
gene.
Cellular stress has also been shown to result in NCC death that can
contribute to craniofacial phenotypes. Knockout of polδ1 or Tcof1
causes DNA damage leading to NCC apoptosis and, ultimately,
craniofacial abnormalities (Jones et al., 2008; Plaster et al., 2006). In
both cases, this apoptosis can be inhibited, and the craniofacial
phenotypes effectively rescued, by the simultaneous attenuation of
p53. Similarly, the non-speciﬁc apoptosis induced by injection of
some morpholinos can also be eliminated by knockdown of p53
(Morcos, 2007). However, the cell death we observe in vgll2a
morphants is p53-independent as these experiments were conducted
in a p53−/−ﬁsh line, suggesting that the phenotypes we observe are
not the result of cellular stress-induced apoptosis and supporting a
role for vgll2a in regulating NCC survival.
The ability of vgll2a-expressing endoderm to rescue pharyngeal
cartilage development in otherwise vgll2a morphant embryos
Fig. 5. Cell death within the pharyngeal arches is increased in vgll2a morphants. Three-dimensional projections of confocal slices of representative uninjected (A,C,E) and vgll2a
morphant embryos (B,D,F) at 24 (A,B) 48 (C,D) and 72 hpf (E,F) stained with zn-8 (anti-Alcama) and anti-activated caspase 3 antibodies in lateral views, and quantiﬁcation of cell
death in uninjected andmorphant embryos (G). Embryos injected with 5 ng vgll2a ATGMO (B,D,F) exhibit a greater number of activated caspase 3 positive cells (red) per μm3within
arches volumes modeled within the white dashed lines based on zn-8 staining (green) relative to uninjected controls (A, C, E), at 24, but not 48 or 72 hpf. (G) Quantiﬁcation of the
average number of active caspase 3 positive cells / 100 μm3 of arch volume per embryo (Student's T Test, **: pb0.01). Error bars represent standard error of themean. Numbers at the
base of each bar represent the number of embryos counted for each condition. Scale bar=100 μm. Anterior is to the left in panels A-F.
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hypothesize that vgll2a regulates a survival signal originating from the
pharyngeal endoderm and/or ectoderm that is required for NCC
maintenance following migration into the pharyngeal arches. Similar
mechanisms have been described in other vertebrate systems as a
means of eliminating cells that have been mispatterned or otherwise
strayed from their developmental path (Raff, 1992; Raff et al., 1994).
The endoderm in particular has been shown to be a potent source of
signals required for NCC survival; the zebraﬁsh casanova (cas/sox32)
mutant lacks all endoderm and exhibits cranial NCC death as a
consequence (David et al., 2002).
We have described a novel role for vgll2a in promoting survival of
NCCs. Our data demonstrate that vgll2a is required for neural crest cell
survival within the arches at around 24 hpf, resulting in a reduction in
cranial neural crest cell number in vgll2a morphants. Consequently,
the anterior cartilage elements in embryos injected with 5 ng of vgll2a
ATGMO are severely hypoplastic at 5 dpf when compared to controls.
The absence of the ceratobranchial cartilages in these morphants may
be due to a failure in the accumulation of enough NCCs to meet the
critical mass required for chondrogenesis of these elements (Hall,
1987). Indeed, the posterior arches of vgll2a morphants failed to
express barx1 and sox9a during chondrogenesis. Neural crest cells that
fail to undergo chondrogenesis but persist may remain undifferen-
tiated and, subsequently, be eliminated in a second wave of cell death
that occurs after 72 hpf, the last time point that we assayed.
Interestingly, the TEAD transcription factors have been shown to
interact with the transcription co-activator YAP1 as part of the Hippo
pathway, which controls organ size by regulating apoptosis and
proliferation and has also been implicated in cancer (Goulev et al.,2008; Wu et al., 2008; Zhang et al., 2008; Zhao et al., 2010). It is
possible that VGLL, TEAD, and YAP1 function together to regulate
hippo signaling, though this has not been examined. The Drosophila
homologues of these proteins, however, have been shown to act
together to regulate transcription (Goulev et al., 2008). The recent
report that yap1 knockdown by morpholino injection in zebraﬁsh
results in increased apoptosis and hypoplastic pharyngeal cartilages
(Jiang et al., 2009) similar to the phenotypes we report here in vgll2a
morphant embryos lends credence to the possibility that VGL, TEAD,
and YAP1 function together in vertebrates as well. It is intriguing to
consider the possibility, then, that the vgll2a-regulated survival signal
is a Hippo target. Indeed, Hippo signaling has been shown to regulate
the expression of many secreted growth factors and extracellular
signaling molecules that would represent plausible candidates for
such a survival signal (Hao et al., 2008; Zhang et al., 2009, 2011; Zhao
et al., 2008). It would be interesting to determine if such Hippo
effectors are expressed in the pharyngeal epithelia, whether Vgll2a
regulates their expression, and if they are required for neural crest
survival.
vgll2a regulation by FGF and RA
Opposing FGF and RA signals are a theme in the regulation of
multiple events during embryonic development (Diez del Corral et al.,
2003; Mercader et al., 2000). This paradigm may be reﬂected in our
ﬁnding that expression of vgll2a within the pharyngeal epithelia, but
not other domains of expression, is regulated positively by FGF and
negatively by RA. In support of our data, expression of Xenopus vgll2 is
also responsive to FGF signaling in animal cap experiments (Faucheux
Fig. 6. Expression of vgll2a in the pharyngeal endoderm is sufﬁcient for facial cartilage development. Schematic representation of transplantation performedwith endodermally fated
wildtype vgll2 expressing (WT) cells (A). To create mosaic embryos that express vgll2awithin the pharyngeal endoderm but are otherwise Vgll2a knockdown in all other cells, donor
embryos were injected at the single-cell stage with cas/sox32 mRNA to fate these embryos to become endoderm along with a rhodamine-dextran tracer. At blastoderm stage, cells
were transplanted from the margin of these endodermally fated donor embryos to the margin of vgll2a morphant embryos (A). In lateral (B,) and dorsoposterior (C) views of a
representative mosaic embryo at 30 hpf following transplantation, these cells appear red by ﬂuorescent microscopy and often contribute to one side of the pharyngeal endoderm. In
ventral views at 5 dpf, alcian blue staining reveals that pharyngeal cartilage development is completely (wholemount, D; and dissected, E) or partially (wholemount,F) rescued in
some of these embryos. Quantiﬁcation of number vgll2amorphant embryos that exhibited rescue upon introduction of endoderm from embryos expressing vgll2a (G). Rescue was
scored as rescue of one cartilage element, rescue of more than one cartilage element, or rescue of all cartilage elements (full rescue) relative to morphants and expressed as a percent
of the total number of mosaic embryos analyzed (G, n=46). 26% of endoderm transplants showed partial or full rescue. Dotted lines mark the approximate midline. cb,
ceratobranchial; ch, ceratohyal; hs, hyosymplectic; m, Meckel's cartilage; pq, palatoquadrate. Anterior is to the right in B and to the left in D-F.
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modulating these signaling pathways for only 1 h. The short time
frame of these treatments suggests that vgll2a could be a direct
transcriptional target of RA and FGF signaling and, as such, is
inconsistent with the possibility that one signaling pathway might
be affecting the activity of the other. We have also observed this
regulation at 35 and 48 hpf (data not shown), demonstrating that FGF
and RA regulate vgll2a expression within the pharyngeal arches
throughout craniofacial development.
It is interesting to consider where the FGF and RA signals that
regulate pharyngeal expression of vgll2amight originate. In zebraﬁsh,
aldh1a2, which encodes the retinaldehyde dehydrogenase responsiblefor RA synthesis, is expressed in the posterior arches at 24 hpf (Vaccari
et al., 2010; Wilm and Solnica-Krezel, 2005), when we have shown
vgll2a to be regulated by RA. As such we believe this likely represents
the source of RA that regulates expression within the pharyngeal
epithelia. Given that there are at least 28 FGF ligands encoded by the
zebraﬁsh genome (Itoh, 2010), it is difﬁcult to speculate about the
source of the FGFs that drive pharyngeal expression of vgll2a. A
number of studies have emphasized the importance of FGF8 in
craniofacial development (Abu-Issa et al., 2002; Crump et al., 2004;
Macatee et al., 2003), but we were unable to detect fgf8 expression
within the arches by ISH at 24 hpf (data not shown), when we have
shown vgll2a to be regulated by FGF signaling. Fgf3 has also been
Fig. 7. Expression of vgll2a is regulated by FGF and RA signaling. Dorsal views of embryos processed by ISH using a vgll2a probe following treatment with DMSO (control, A), SU5402 (B),
DEAB (C), and RA (E). Embryos treatedwith 20 μMSU5402 to inhibit FGF signaling for one hour from23 to 24 hpf and processed for by ISH for vgll2a expression show a reduction in vgll2a
mRNAin the endodermalandectodermalpharyngeal epithelia surrounding thearches (B,n=22/23) compared toDMSO-treatedcontrol embryos (A, n=32/34). Embryos treated from23
to 24 hpfwith 100 μMDEAB to inhibit RA synthesis (C, n=25/27) exhibit increased vgll2a expression in the pharyngeal epithelia while treatmentwith 100 nMall-trans RA (D, n=25/25)
results in reduced expression of vgll2a in this domain. Other domains of vgll2a expression were not affected in these treatments (data not shown). Anterior is to the left in all panels.
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expressed prominently within the pharyngeal pouches in zebraﬁsh
at 24 hpf (David et al., 2002; Walshe and Mason, 2003). Thus, we
believe Fgf3 could represent an FGF source capable of regulating vgll2a
expression. It is likely, however, that Fgf3 could act redundantly with
one or more additional Fgf ligands such as Fgf8-related Fgf24, which is
also expressed in the pharyngeal pouches in zebraﬁsh (Jovelin et al.,
2009; Mercader et al., 2006).
FGF has been implicated in NCC survival (Abu-Issa et al., 2002;
Nissen et al., 2003; Trokovic et al., 2003; Yang et al., 2010) and cranial
NCC death has been shown to result from an increase or decrease in RA
(Begemann et al., 2001; Dickman et al., 1997; Sulik et al., 1988), which
has been shown to regulate apoptosis in a myriad of ways (reviewed in
Noy, 2010). As such, vgll2a could also be acting as an effector of FGF and/
or RA signaling in the regulation of cell death. FGF and RA signaling have
also been shown to regulate endodermal pouchmorphogenesis (Crump
et al., 2004; Kopinke et al., 2006; Linville et al., 2009). We ﬁrst observe
vgll2a expression in thepharyngeal endoderm in a subset of cells as they
began to evaginate to form the ﬁrst endodermal pouch and its
expression in the pharyngeal endoderm persists throughout pouch
morphogenesis. At 38 hpf, all of the endodermal pouches have formed,
but in vgll2a morphants they appear shorter and wider than in
uninjected embryos. This could suggest that vgll2a is required forFig. 8.Model of vgll2a function during zebraﬁsh craniofacial development. Expression of vgll
(A). Within the endoderm (orange cells) and perhaps the ectoderm (blue cells), vgll2a regula
neural crest cells (green cells) around 24 hpf. In the presence of vgll2a expression (A), these n
expression (B), the pharyngeal epithelia fails to express the vgll2a-regulated survival signal a
5 dpf, only neural crest cells in close enough association with one-another meet the critical m
absent.endodermal pouchmorphogenesis, perhaps bymediating the activity of
FGF and/or RA signaling pathways. Interestingly, Vg has recently been
shown to be required in Drosophila for cell shape changes in the
developing wing disc pouch (Widmann and Dahmann, 2009), suggest-
ing vgll2a could play an analogous role in pharyngeal pouch develop-
ment. Alternatively, the aberration in endodermal pouch morphology
could be secondary to the cranial NCC death that occurs in vgll2a
morphants; the pouches may simply expand in the absence of physical
constraint. Further experiments are required to determine how vgll2a
affects pouch morphology.
In summary, we believe that vgll2a represents an important
regulator of NCC survival during craniofacial development (Fig. 8). Its
expression within the pharyngeal epithelia is regulated positively by
FGFs and negatively by RA and is required for survival of adjacent
NCCs around 24 hpf. We postulate that at this time-point NCCs
require a signal from the pharyngeal epithelia for their survival and
that expression of this signal is regulated by vgll2a expression. Thus, in
vgll2amorphants, a portion of these NCCs die, reducing the number of
NCC cartilage progenitors and subsequently resulting in cartilage
elements that are either reduced in size or absent, having failed to
reach the critical mass required for chondrogenesis.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.06.034.2awithin the pharyngeal epithelia is regulated positively by FGFs and negatively by RA
tes expression of a survival signal secreted by these epithelia and required for survival of
eural crest cells go on to form the pharyngeal cartilages by 5 dpf. In the absence of vgll2a
nd a subset of neural crest cells undergo caspase-mediated cell death around 24 hpf. By
ass required for chondrogenesis, resulting in cartilage elements that are hypoplastic or
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